Tamoxifen infertility

By: tlee Date: 18-Feb-2019
Ovulation Induction Treatment Tennessee Reproductive Medicine

Ovulation Induction Treatment Tennessee Reproductive Medicine

The polycystic ovary syndrome (PCOs) affects 5-10% of reproductive age women and it is the most common cause of unovulatory infertility. Comparison between effect of adding tamoxifen to clomiphene and only clomiphene for infertility managment in PCO-patients (At infertility & Bahman clinic). The aim of this clinical trial was to compare the combination therapy of letrozole and clomiphene with letrozole and tamoxifen as an infertility treatment in women with the polycystic ovary syndrome. In this study 9 infertile women between 18-40 years with the polycystic ovary syndrome who had no major medical disorders enrolled in this clinical trial. Patients were randomized in to 2 groups: one group was treated with Clomiphene Citrate (CC) 50 mg twice daily and letrozole 2.5 mg twice daily for 5 days (from day 3-7 of menstrual cycle) and group 2 took tamoxifen 10 mg twice daily and letrozole 2.5 mg twice daily for 5 days (from day 3-7 of menstrual cycle). Trans vaginal ultrasonography (TVS) was performed at the day 7 in order to determine number of follicles, size of follicles and Endometrial Thickness (ET). Pregnancy rate in the group of women who received tamoxifen and letrozole (Group B) was more than women who received CC and letrozole (Group A) (2.2% in group A vs. 17.8% in group B) that there is significant difference between two groups (p = 0.01). Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: Meta-analyses of randomized trials of monotherapy and switching strategies. In 2006, the large STAR clinical study concluded that raloxifene is equally effective in reducing the incidence of breast cancer, but after an average 4-year follow-up, although the difference was not statistically significant, there were 36% fewer uterine cancers and 29% fewer blood clots in women taking raloxifene than in women taking tamoxifen. Tamoxifen improves fertility in males with infertility by disinhibiting the hypothalamic-pituitary-adrenal axis (via ER antagonism) and thereby increasing the secretion of luteinizing hormone and follicle-stimulating hormone and increasing testicular testosterone production. It is taken as a preventative measure in small doses, or used at the onset of any symptoms such as nipple soreness or sensitivity. Other drugs are taken for similar purposes such as clomiphene citrate and the anti-aromatase drugs which are used in order to try to avoid the hormone-related adverse effects. Occasionally tamoxifen is used in treatment of the rare conditions of retroperitoneal fibrosis A report in September 2009 from Health and Human Services' Agency for Healthcare Research and Quality suggests that tamoxifen, raloxifene, and tibolone used to treat breast cancer significantly reduce invasive breast cancer in midlife and older women, but also increase the risk of adverse side effects. Some cases of lower-limb lymphedema have been associated with the use of tamoxifen, due to the blood clots and deep vein thrombosis (DVT) that can be caused by this medication. Resolution of the blood clots or DVT is needed before lymphedema treatment can be initiated.

Treating Idiopathic Male <i>Infertility</i> with a Combination of
Treating Idiopathic Male Infertility with a Combination of

Male infertility; Antioxidant; Oligospermia; Oligoasthenozoospermia OA; Tamoxifen citrate. Infertility is one of the most important issues among married couples and it represents a major. Medical information for Tamoxifen including its dosage, uses, side, effects, interactions, pictures and warnings. Tamoxifen. Print Download PDF Send by Name of the medicinal product.

Tamoxifen infertility
Rating 4,3 stars - 388 reviews